R&D
Universities and pharma companies need each other to create world-changing medicines
Academics and pharma executives seemingly live in very different …
19770 items found
News
New RUBY readout buoys GSK’s Jemperli in endometrial cancer
GSK has said that a regimen of PD-1 inhibitor Jemperli with PARP …
Digital
To fight rare diseases, win the data battle first
Innovation is the key to evolution. In the pharmaceutical space, …
News
CHMP backs Biogen’s Skyclarys for Friedreich’s ataxia
Biogen’s Skyclarys is on course to becoming the first approved …
Digital
AI-driven text analytics improve clinical trial processes
New AI-driven text analytics solutions have the potential to …
News
BMS’ LAG-3 RELATIVITY theory fails futility test
Bristol-Myers Squibb has abandoned a bid to extend the indications of …
News
NICE’s new cholesterol guidance looks beyond statins
NICE has set a new target for cholesterol levels in people who have …
News
MSD claims 2nd FDA approval for Welireg, in kidney cancer
The FDA has approved MSD’s oral HIF-2 alpha inhibitor Welireg for a …
R&D
Threats impacting the pharmaceutical industry in 2024
As we approach 2024, what will the next 12 months have in store for …
News
Enrolment starts in trial of AI-powered Parkinson’s therapy
Patient recruitment is now underway in a clinical trial of Newel …
News
MSD, Moderna cancer vaccine aces melanoma study
MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown …
Digital
How large language models can help prevent the next pandemic
The COVID-19 pandemic was a calamity in more ways than one: lost …
News
Nasdaq debutante Septerna swells its IPO to $331m
Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
